S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Biden's Plan to Confiscate Your Cash? (Ad)
Italy's Lake Garda shrinks to near-historic low amid drought
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Germany urged to cap heat in offices this winter to save gas
Will This Be the Worst U.S. Crisis Ever? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Biden's Plan to Confiscate Your Cash? (Ad)
Italy's Lake Garda shrinks to near-historic low amid drought
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Germany urged to cap heat in offices this winter to save gas
Will This Be the Worst U.S. Crisis Ever? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Biden's Plan to Confiscate Your Cash? (Ad)
Italy's Lake Garda shrinks to near-historic low amid drought
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Germany urged to cap heat in offices this winter to save gas
Will This Be the Worst U.S. Crisis Ever? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Biden's Plan to Confiscate Your Cash? (Ad)
Italy's Lake Garda shrinks to near-historic low amid drought
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Germany urged to cap heat in offices this winter to save gas
Will This Be the Worst U.S. Crisis Ever? (Ad)
OTCMKTS:CCEL

Cryo-Cell International - CCEL Stock Forecast, Price & News

$5.76
+0.15 (+2.67%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$5.61
$5.84
50-Day Range
$5.20
$6.58
52-Week Range
$5.00
$14.16
Volume
4,892 shs
Average Volume
3,276 shs
Market Capitalization
$48.31 million
P/E Ratio
30.31
Dividend Yield
N/A
Price Target
N/A
CCEL stock logo

About Cryo-Cell International (OTCMKTS:CCEL) Stock

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Receive CCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter.

CCEL Stock News Headlines

Why this German company is expanding in Knightdale
How 2020's Hottest IPOs Have Performed In 2021
Cryo-Cell Reports Q3 2021 Revs $7.5M
See More Headlines
Receive CCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter.

CCEL Company Calendar

Last Earnings
7/11/2022
Today
8/14/2022
Next Earnings (Estimated)
10/13/2022
Fiscal Year End
11/30/2022

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CCEL
Employees
83
Year Founded
N/A

Profitability

Net Income
$2.08 million
Pretax Margin
6.98%

Debt

Sales & Book Value

Annual Sales
$28.89 million
Cash Flow
$0.42 per share
Book Value
$0.49 per share

Miscellaneous

Free Float
5,146,000
Market Cap
$48.31 million
Optionable
Not Optionable
Beta
0.54

Key Executives

  • Mr. David I. Portnoy (Age 59)
    Chairman & Co-CEO
    Comp: $1.22M
  • Mr. Mark L. Portnoy (Age 58)
    Co-CEO & Director
    Comp: $873.34k
  • Ms. Jill M. Taymans (Age 52)
    CFO & VP of Fin.
    Comp: $205.42k
  • Mr. Oleg Mikulinsky (Age 49)
    Chief Information Officer
    Comp: $326.35k
  • Dr. Joanne Kurtzberg M.D.
    Medical Director and Member of Medical & Scientific Advisory Board













CCEL Stock - Frequently Asked Questions

How have CCEL shares performed in 2022?

Cryo-Cell International's stock was trading at $11.60 at the beginning of the year. Since then, CCEL stock has decreased by 50.4% and is now trading at $5.7581.
View the best growth stocks for 2022 here
.

When is Cryo-Cell International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 13th 2022.
View our CCEL earnings forecast
.

How were Cryo-Cell International's earnings last quarter?

Cryo-Cell International, Inc. (OTCMKTS:CCEL) issued its quarterly earnings data on Monday, July, 11th. The company reported $0.07 earnings per share for the quarter. The business had revenue of $7.63 million for the quarter. Cryo-Cell International had a trailing twelve-month return on equity of 38.25% and a net margin of 5.68%.

What other stocks do shareholders of Cryo-Cell International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryo-Cell International investors own include NVIDIA (NVDA), Overstock.com (OSTK), Avid Technology (AVID), Boeing (BA), Enphase Energy (ENPH), OPKO Health (OPK), Riot Blockchain (RIOT), Aldeyra Therapeutics (ALDX), Alimera Sciences (ALIM) and Allena Pharmaceuticals (ALNA).

What is Cryo-Cell International's stock symbol?

Cryo-Cell International trades on the OTCMKTS under the ticker symbol "CCEL."

Who are Cryo-Cell International's major shareholders?

Cryo-Cell International's stock is owned by a variety of retail and institutional investors. Top institutional investors include Massmutual Trust Co. FSB ADV (1.47%). Insiders that own company stock include Brian L Sheehy, David Portnoy, George Gaines and Mark L Portnoy.
View institutional ownership trends
.

How do I buy shares of Cryo-Cell International?

Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cryo-Cell International's stock price today?

One share of CCEL stock can currently be purchased for approximately $5.76.

How much money does Cryo-Cell International make?

Cryo-Cell International (OTCMKTS:CCEL) has a market capitalization of $48.31 million and generates $28.89 million in revenue each year. The company earns $2.08 million in net income (profit) each year or $0.19 on an earnings per share basis.

How can I contact Cryo-Cell International?

Cryo-Cell International's mailing address is 700 Brooker Creek Boulevard Suite 1800, Oldsmar FL, 34677. The official website for the company is www.cryo-cell.com. The company can be reached via phone at (813) 749-2100, via email at investors@cryo-cell.com, or via fax at 813-855-4745.

This page (OTCMKTS:CCEL) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.